Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $202,807 - $236,058
-2,639 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $2,237 - $2,615
-30 Reduced 1.12%
2,639 $227,000
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $196,892 - $223,155
2,669 New
2,669 $215,000
Q2 2021

Aug 06, 2021

SELL
$80.5 - $88.01 $194,166 - $212,280
-2,412 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$76.38 - $86.03 $19,095 - $21,507
-250 Reduced 9.39%
2,412 $203,000
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $5,874 - $6,804
75 Added 2.9%
2,662 $214,000
Q1 2020

May 12, 2020

BUY
$71.57 - $93.3 $185,151 - $241,367
2,587 New
2,587 $210,000
Q3 2019

Nov 08, 2019

SELL
$81.4 - $89.78 $309,971 - $341,882
-3,808 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$73.44 - $82.41 $279,659 - $313,817
3,808 New
3,808 $312,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Meristem Family Wealth, LLC Portfolio

Follow Meristem Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meristem Family Wealth, LLC with notifications on news.